SANTANDER. Researchers at Marqués de Valdecilla University and the Valdecilla Sanitary Research Institute (IDIVAL), depending on the Ministry of Health, have discovered that a genetic variant in the PLCG2 gene protects against various forms of dementia.
According to the results of the study conducted in collaboration with researchers from & # 39; a UMC University of Amsterdam, this genetic variety does not only protect against the illness Alzheimer'sBut also against other forms of neurodegenerative disorders such as fronto-temporal dementia and dementia of Lewy bodies, the government of Cantabria informs.
Dr. Pascual Sanchez-Juan, a neurologist at the Valdecilla Cognitive Impairment Unit and co-author of & # 39; s study, has set the discovery value in value, "to give it our important stories about what the genetic characteristics are and the metabolic pathway is a long-term dementia-free life. "
He explained that so far it was known that one of these genetic variant carriers had a "twice lower" problem for developing Alzheimer's dementia in comparison to non-carriers.
Now, he says, "it seems that the treatment of the variant also protects against other forms of neurodegeneration and that bearer of this variant is double as reaches a hundred years without diamonds."
Dr. Sánchez-Juan has argued that the study also determines that the PLCG2 genera are often followed in hundreds-year-olds followed by researchers at the University of Amsterdam.
This genetic variant in the PLCG2 gene, which plays an important role in the immune system, leads to a change in the structure of the PLCG2 protein, which is probably its function in & # 39; 39; changing immune responses, & # 39; said the neurologist.
He also estimates that Valdecilla Cognitive Impairment Unit is currently the project & # 39; Cohorte Valdecilla & # 39; develops for memory and brain research, using it in & # 39; Invite a 55-year-old person to better understand the factors of risk and protectors associated with the development of diminutive power.